A ground-breaking genetic test that could prevent critically ill newborn babies going deaf if treated with a commonly used antibiotic, is being trialled across 14 NHS neonatal units.
Read more
Researchers have shown that their system, developed at MFT, can identify more breast cancer patients who are eligible for testing for inherited faulty genes that can cause breast cancer.
Read more
To celebrate this year’s #Red4Research Day on Friday 20 September, Research Midwife, Emma Clark shares her career journey and her hopes to inspire others to get involved in research.
Read more
An innovative bedside genetic test developed by MFT researchers could dramatically improve outcomes for thousands of people in the UK affected by stroke each year.
Read more
Women treated for ovarian cancer caused by an inherited faulty gene have a lower risk of developing breast cancer following that treatment, new research from MFT has revealed.
Read more
Researchers are to trial a ground-breaking screening test for pre-eclampsia, a potentially life-threatening condition affecting pregnant women and their unborn babies.
Read more
Manchester University NHS Foundation Trust (MFT) has now started a recommendations review on the benefits, limitations and implications of transcutaneous bilirubin (TCB) monitoring devices.
Read more
The Academy of Medical Science has elected Professor Bill Newman, Consultant in Genomic Medicine, Manchester Centre for Genomic Medicine, Saint Mary’s Hospital, to its prestigious Fellowship.
Read more
